These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 25360133)
1. Engineered bacteriophage lysins as novel anti-infectives. Yang H; Yu J; Wei H Front Microbiol; 2014; 5():542. PubMed ID: 25360133 [TBL] [Abstract][Full Text] [Related]
2. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii. Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452 [TBL] [Abstract][Full Text] [Related]
3. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria. Heselpoth RD; Euler CW; Schuch R; Fischetti VA Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344 [TBL] [Abstract][Full Text] [Related]
4. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci. Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC Front Microbiol; 2020; 11():574739. PubMed ID: 33324362 [TBL] [Abstract][Full Text] [Related]
6. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens. Fischetti VA Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus. Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012 [TBL] [Abstract][Full Text] [Related]
8. Lysins: the arrival of pathogen-directed anti-infectives. Pastagia M; Schuch R; Fischetti VA; Huang DB J Med Microbiol; 2013 Oct; 62(Pt 10):1506-1516. PubMed ID: 23813275 [TBL] [Abstract][Full Text] [Related]
9. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion. Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047 [TBL] [Abstract][Full Text] [Related]